Magnesium Acetate Tetrahydrate
Daten werden ergänzt – meist innerhalb einer Minute fertig
Grundinformationen
- CAS
16674-78-5- Standard-SMILES
CC(=O)[O-].CC(=O)[O-].O.O.O.O.[Mg+2]- InChIKey
XKPKPGCRSHFTKM-UHFFFAOYSA-L- Summenformel
- C4H14MgO8
- Durchschnittliche Molmasse
- 214,45 g/mol
- Monoisotopische Masse
- 214,05390911
Überblick
Magnesium acetate tetrahydrate is a hydrated form of anhydrous magnesium acetate salt with the chemical formula of Mg(CH3COO)2 • 4H2O. As a salt form of magnesium, magnesium acetate is one of the bioavailable forms of magnesium and forms a very water soluble compound. Magnesium is an essential element and second most abundant cation in the body that plays a key role in maintaining normal cellular function such as production of ATP and efficient enzyme activity. Magnesium acetate tetrahydrate can be used as an electrolyte supplementation or a reagent in molecular biology experiments.
Namen und Bezeichner
- Bevorzugter Name
- Magnesium Acetate Tetrahydrate
- IUPAC
- magnesium;diacetate;tetrahydrate
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
16674-78-5- PubChem CID
- 134717
- DTXSID
DTXSID60168170- ChEMBL
CHEMBL3989858- UNII
- I01G0EJC3B
- EC Number
- 605-451-2、680-379-2
Eigenschaften
Berechnete StruktureigenschaftenWird ergänzt
- Polarare Oberfläche (TPSA)
- 84,3 Ų
- H-Brücken-Donoren
- 4
- H-Brücken-Akzeptoren
- 8
- Frei drehbare Bindungen
- 0
- Schwere Atome
- 13
- Formalladung
- 0
- Komplexität
- 25,5
Experimentelle und physikochemische Eigenschaften
Human Drugs
FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
This chemical does not meet GHS hazard criteria for 100% (90 of 90) of all reports.
Not Classified
Aggregated GHS information provided per 90 reports by companies from 2 notifications to the ECHA C&L Inventory.
Not Classified
Gefahrenhinweise
Regulatory Information
Chemical: Acetic acid, magnesium salt, tetrahydrate
Acetic acid, magnesium salt, hydrate (2:1:4) is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Acetic acid, magnesium salt, hydrate (2:1:4) are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)
Magnesium acetate, tetrahydrate: Non hazardous
Hazard Classes and Categories
Not Classified
Not Classified
Sicherheit und Schutzausrüstung
Protective Action Criteria (PAC)
46 [mg/m3]
490 [mg/m3]
3000 [mg/m3]
Chemie und Industrie
Pharmakologische Informationen
Pharmacodynamics
Magnesium is an essential cofactor for many enzymatic reactions such as protein synthesis and ATP production. It also participates in adenylyl cyclase pathway and tyrosine kinase signalling pathways. Magnesium may also play a role in regulating glucose metabolism. It serves as an essential cation for a number of biochemical processes involved in nerve signaling, bone mineralization and muscle contractions.
Mechanism of Action
Magnesium is an essential element that regulates vascular function and blood pressure. Magnesium ions electrostatically stabilize the adenylyl cyclase complex and enhance its catalytic actions and production of cAMP. They also regulate the level of phosphorylation in various pathways by the formation of a transition state of phosphoryl transfer reaction by protein kinases and stabilize ATP binding to protein kinases via electrostatic interactions. Many metabolic enzymes involved in glycolysis and Krebs cycle are magnesium-dependent. Studies show that magnesium ions decrease blood pressure and that magnesium deficiency is often associated with vasoconstriction and increased blood pressure. Magnesium ions also regulate other ions entering and exiting the cell membrane by acting as a ligand in N-methyl-D-aspartate receptor. Magnesium-containing laxatives cause diarrhea through water retention and increased fecal mass, which stimulates peristalsis. When used as an electrolyte supplement, magnesium acetate tetrahydrate induces diuresis and a metabolic alkalinizing effect.
FDA Pharmacological Classification
MAGNESIA ACETICA
Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Calculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Laxative [EPC]; Magnesium Ion Exchange Activity [MoA]
Absorption, Distribution and Excretion
Intestinal absorption is achieved mainly through passive diffusion.
Mainly renal exctretion, where up to 97% of magnesium may be excreted renally during hypermagnesemia.
Magnesium ions display approximate volume of distribution of 0.2 to 0.4 L/kg
Verwendung und Herstellung
Use Classification
EPA Safer Chemical Functional Use Classes -> Processing Aids and Additives
Safer Chemical Classes -> Green circle - The chemical has been verified to be of low concern
Anbieter100 Anbieter
Zugehörige Reaktionen
Notizen zur Verbindung
Wird geladen…